In China gene-editing trial, 2 children improved, 1 died and 1 withdrew
Four seriously ill Chinese boys who would almost certainly have died in their twenties from a rare inherited disease received the same highly anticipated gene-editing drug. More than a year later, a set of cruel and contradictory data emerged. Two boys gained the strength to walk farther. One boy showed no improvement in gait and subsequently withdrew from the trial. And the fourth boy’s heart…
Read original article on News - South China Morning Post →Related news
-
Chinese astronomers find planets that somehow avoided death by red giant stars
Science
Space
-
Cruise ship suspends global voyage in Cambodia over fuel prices, hundreds disembark
Business
Corporate
Cambodia
-
Huawei’s Tau Scaling Law roll-out reaches base stations in blow to US chip curbs
Technology
AI
China
-
Why Hong Kong rents are hitting records while home price gains lose momentum
Economy
Housing Market
Hong Kong
-
Japan’s US$6 billion port plan aims to revive Bangladesh’s bruised economy
Economy
Trade
Bangladesh
-
Chinese student encouraged by farm owner enrols in master’s programme 6 years later
Good News
China
-
Chinese drug sector’s stature grows at major cancer conference
Health
Medicine
Global
-
At least 30 dead in Spain after high-speed trains collide
Environment & Nature
Natural Disasters
Spain